Calvet et al. showed a 45% decrease in median CD4+/CD8+ T cell ratio [1.7, (1.7 IQR) vs. 3.1 (2.4 IQR)] in critical patients compared to non-critical COVID-19 adult patients (39). This evidence concerns the gene CD4 and COVID-19.